NI
VRTX icon

Natural Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Natural Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$565K Buy
1,265
+92
+8% +$42.9K 0.14% 143
2025
Q4 		$531K Buy
1,173
+225
+24% +$97K 0.13% 148
2025
Q3 		$371K Sell
948
-68
-7% -$28.4K 0.09% 169
2025
Q2 		$452K Buy
1,016
+199
+24% +$91.7K 0.12% 152
2025
Q1 		$396K Buy
817
+187
+30% +$87.1K 0.11% 162
2024
Q4 		$253K Buy
+630
New +$292K 0.07% 206

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Natural Investments's VRTX Position: Q1 2026 in Review

Natural Investments increased its Vertex Pharmaceuticals (VRTX) stake by 7.8% in Q1 2026, buying an estimated $42.9K and bringing the position to 1,265 shares worth $565K. The position accounts for 0.14% of the portfolio, ranked #143.

Natural Investments first reported a position in VRTX in Q4 2024 and has held it in 6 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Natural Investments held 1,265 shares of Vertex Pharmaceuticals worth $565K as of Q1 2026.
  • Natural Investments bought 92 Vertex Pharmaceuticals shares in Q1 2026, an estimated $42.9K.
  • Vertex Pharmaceuticals made up 0.14% of Natural Investments's portfolio in Q1 2026, its #143 holding.
  • Natural Investments first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Natural Investments's 13F filing for Q1 2026, filed 1 May 2026.